Rep. Rosa DeLauro Reintroduces The "Recall Unsafe Drugs Act"

WASHINGTON, DC - JANUARY 10: David Light, (L), founder and CEO of Valisure speaks while flanked by Rep. Rosa DeLauro, (D-CT), during a news conference to reintroduce the "Recall Unsafe Drugs Act," at the U.S. Capitol on January 10, 2020 in Washington, DC. A new study published in the Journal of the American Medical Association by researchers at Valisure, the Memorial Sloan Kettering Cancer Center and Stanford University has found an association between ranitidine use and several forms of cancer. (Photo by Mark Wilson/Getty Images)
WASHINGTON, DC - JANUARY 10: David Light, (L), founder and CEO of Valisure speaks while flanked by Rep. Rosa DeLauro, (D-CT), during a news conference to reintroduce the "Recall Unsafe Drugs Act," at the U.S. Capitol on January 10, 2020 in Washington, DC. A new study published in the Journal of the American Medical Association by researchers at Valisure, the Memorial Sloan Kettering Cancer Center and Stanford University has found an association between ranitidine use and several forms of cancer. (Photo by Mark Wilson/Getty Images)
Rep. Rosa DeLauro Reintroduces The "Recall Unsafe Drugs Act"
PURCHASE A LICENSE
How can I use this image?
$499.00
USD

DETAILS

Restrictions:
Contact your local office for all commercial or promotional uses. Full editorial rights UK, US, Ireland, Canada (not Quebec). Restricted editorial rights for daily newspapers elsewhere, please call.
Credit:
Mark Wilson / Staff
Editorial #:
1198692275
Collection:
Getty Images News
Date created:
January 10, 2020
Upload date:
License type:
Release info:
Not released. More information
Source:
Getty Images North America
Object name:
mw010083_20200110124659190.jpg
Max file size:
4752 x 3381 px (15.84 x 11.27 in) - 300 dpi - 3 MB